EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,972,000 | -39.3% | 64,274 | -41.5% | 0.57% | -45.6% |
| Q4 2020 | $9,837,000 | +20.1% | 109,786 | +38.4% | 1.04% | -13.0% |
| Q3 2020 | $8,194,000 | +100.8% | 79,300 | +53.7% | 1.20% | +83.3% |
| Q2 2020 | $4,080,000 | -24.7% | 51,588 | -44.9% | 0.65% | -45.5% |
| Q1 2020 | $5,416,000 | -1.6% | 93,603 | -8.2% | 1.20% | +33.3% |
| Q4 2019 | $5,502,000 | -19.4% | 101,979 | -21.9% | 0.90% | -22.2% |
| Q3 2019 | $6,826,000 | -4.8% | 130,573 | -12.1% | 1.16% | +4.2% |
| Q2 2019 | $7,173,000 | +28.5% | 148,479 | +34.4% | 1.11% | +28.1% |
| Q1 2019 | $5,580,000 | +77.0% | 110,446 | +107.6% | 0.87% | +38.3% |
| Q4 2018 | $3,153,000 | -64.0% | 53,192 | -60.0% | 0.63% | -43.3% |
| Q3 2018 | $8,758,000 | – | 133,040 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |